000			02909nam a22002537a 4500
001			20241021091349.0
003			OCoLC
005			20241021091736.0
008			241021b |||||||| |||| 00| 0 eng d
020			_a978-3-319-27014-2
020			_a 978-3-319-27016-6 (eBook)
040			_cddc
041			_aEnglish
082			_a 616.994 061 NAV
100			_qRudolph M. Navari
245			_aManagement of Chemotherapy-Induced Nausea and Vomiting _bNew Agents and New Uses of Current Agents
260			_aLondon | _bSpringer International Publishing Switzerland | _c 2016
300			_a187 Pages
300			_aIncludes References
520			_aThis book provides a comprehensive review of new agents, a detailed description of new uses of current agents, and an integration of the available agents in clinical practice. A description of a detailed clinical approach provides clinical practitioners with the most up-to-date recommendations for the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV) in various clinical settings. CINV is one of the most feared treatment related toxicities. Patient surveys for the past thirty years consistently demonstrate patients’ perception of deterioration in quality of life due to chemotherapy treatments. The introduction of the antiemetics, serotonin 5-HT3 receptor antagonists and the neurokinin-1 receptor antagonists, have improved the control of chemotherapy-induced emesis, but the treatment of chemotherapy-induced nausea remains a significant clinical problem. Patients continue to have quality of life issues which prevent normal functioning during active treatment. New agents such as the second generation 5-HT3 receptor antagonist palonosetron and the new neuroknin-1 receptor antagonists rolapitant and netupitant are being introduced into clinical practice, and it is anticipated that these new agents will improve the control of CINV. Agents such as olanzapine (a FDA approved anti-psychotic), gabapentin (a FDA approved neuroleptic), and ginger (a food additive), which have been used primarily for other indications, are now being tested as potential, effective antiemetics. /div This work represents the first available comprehensive summary that details all new antiemetic agents and, particularly, their clinical role in treating patients; an important reference for practitioners seeking to improve the quality of life of patients undergoing chemotherapy./div
600			_xMedical / Clinical Medicine, Medical / Oncology / General, Medical / Pharmacology, Oncology, Pharmacology, Therapeutics, Medical / Diseases, Medical / Internal Medicine, Medical / Physical Medicine & Rehabilitation, Cancer -- Chemotherapy -- Complications, Chemotherapy, Drugs -- Side effects, Medicine, Nausea -- Chemotherapy, Vomiting -- Chemotherapy.
856			_uDOI 10.1007/978-3-319-27016-6
942			_2ddc _cEB _n0
999			_c29243 _d29243